SYDNEY, January 22, 2019 – George Clinical, headquartered in Sydney, Australia, a global scientifically backed CRO, today announced the appointment of James Cheong to the role of Chief Operating Officer. With extensive management experience spanning over two decades, Cheong brings valuable leadership to George Clinical’s executive team during a period of strong expansion and growth. […]
Read More
Sydney, Australia (May 2, 2017) – George Clinical, a leading full-service CRO in the Asia-Pacific region and Vector Oncology, a Memphis-based leader in oncology research and data analytics, formally announced today that George Clinical has acquired Vector Oncology’s CRO Division. Effective immediately, the transaction has the dual purpose of strengthening the ability of George Clinical […]
Read More
George Clinical is pleased to announce the receipt of their Hong Kong Wholesale Dealer licence issued by the Department of Health on the 3rd April. This licence represents a significant step forward in George Clinical’s operations in Hong Kong, allowing them to apply for a Certificate of Clinical Trial on behalf of the sponsor and […]
Read More
As the world stops to celebrate and reflect on International Women’s Day on the 8th of March, George Clinical is proud to play their part in #beboldforchange. Traditionally the commercial research sector has a larger proportion of female practitioners than men. Indeed, at George Clinical, the proportion female to men at 158:73 and with a […]
Read More
Either because of financial, legal or operational reasons, many companies including those in healthcare, are still stuck in the paper world when it comes to data and document management. Now that technology has become so much more advanced, switching to electronic health data format has a slew of advantages and benefits that can’t and shouldn’t […]
Read More
George Clinical, a leading Asia-Pacific CRO, have now achieved Medidata Rave® accreditation. Adding this platform to George Clinical’s robust stable of electronic data collection systems will allow George Clinical to further enhance the clinical data collection process for a broader range of customers. Headquartered in Sydney with 260 staff operating in 15 countires. George Clinical provides a full […]
Read More
High blood pressure, or hypertension, can be defined as the flow of blood through the arteries being pushed against the inside of the artery walls. The more pressure the blood exerts on the artery walls, the higher the blood pressure. Hypertension has been labelled the silent killer – as it rarely has symptoms. As such, […]
Read More
George Clinical welcomes the development of the INVICTUS program which was launched at the World Heart Federation’s World Congress of Cardiology and Cardiovascular Health recently. The study, supported by Bayer AG and endorsed by the World Heart Federation, will be conducted by George Clinical in China and reinforces the importance of scientific leadership when undertaking […]
Read More
A recent article published in PharmAsia News highlighted the results of ground-breaking research, published in The New England Journal of Medicine (NEJM), that showed a lower dose of intravenous alteplase can reduce bleeds in the brain and improve survival rates in patients with acute ischemic stroke. While the results of ENCHANTED, a predominantly Asian study, […]
Read More
After careful selection and consideration, George Clinical’s (GC) Evon Hui of the Hong Kong office has accepted the position of Associate Director, Business Operations, East Asia (EA) and will be reporting directly to Marisa Petersen, Chief Executive Officer of GC. Evon joined GC in November 2012 as the Regional Clinical Operations Manager (COM) for the […]
Read More
